OXURION (EBR:OXUR) | WebDisclosure

Basculer en Français

10812	Companies
234240	Keywords
163037	Articles
125255	Press releases

Home
Companies
OXURION

PRESS RELEASE

published on 10/02/2025 at 18:00, 10 months 5 days ago

Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
Oxurion NV kondigt ontvangst van transparantiekennisgeving aan en verwerft meerderheidsbelangen in Europese farmaceutische onderaannemers

Transparantiekennisgeving Oxurion NV België Meerderheidsbelangen Farmaceutische Onderaannemers
PRESS RELEASE

published on 10/02/2025 at 18:00, 10 months 5 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV received a transparency notification from Atlas Special Opportunities II, LLC regarding changes in shareholding. The company specializes in acquiring stakes in European pharmaceutical subcontractors. Risks associated with forward-looking statements and planned investments in digital assets are highlighted

Forward-looking Statements Digital Assets Transparency Notification Oxurion NV Pharmaceutical Subcontractors
BRIEF

published on 09/30/2025 at 18:05, 10 months 7 days ago

Résultats Semestriels 2025 d'Oxurion : Analyse Financière et Opérationnelle

Résultats Financiers Actifs Numériques Prévisions Oxurion Sous-traitants Pharmaceutiques
BRIEF

published on 09/30/2025 at 18:05, 10 months 7 days ago

Oxurion 2025 Half-Year Results: Financial and Operational Analysis

Financial Results Digital Assets Forecasts Oxurion Pharmaceutical Subcontractors
PRESS RELEASE

published on 09/30/2025 at 18:00, 10 months 7 days ago

Oxurion maakt halfjaarresultaten 2025 bekend
Oxurion NV, ein in Leuven ansässiges biofarmazeutisches Unternehmen, veröffentlicht eine finanzielle und geschäftliche Halbjahresupdate. Weitere Informationen unter www.oxurion.com

Investitionen Oxurion NV Leuven Biofarmazeutisch Halbjahresupdate
PRESS RELEASE

published on 09/30/2025 at 18:00, 10 months 7 days ago

Oxurion publie ses résultats du premier semestre 2025
Oxurion NV a publié aujourd'hui ses résultats financiers et opérationnels pour le semestre clos le 30 Juin 2025. Consultez le rapport dans la section 'Investors' du site Web de la Société

Résultats Financiers Investissements Rapport Semestriel Oxurion NV Opérationnels
PRESS RELEASE

published on 09/30/2025 at 18:00, 10 months 7 days ago

Oxurion Publishes First Half 2025 Results
Oxurion NV releases financial and business update for the six-month period ending June 30, 2025. The half-year report is available on the company's website. Oxurion specializes in acquiring pharmaceutical subcontractors

Acquisition Business Update Pharmaceutical Financial Update Oxurion NV
BRIEF

published on 09/16/2025 at 18:05, 10 months 21 days ago

Oxurion et Axiodis CRO misent sur l'IA pour révolutionner les essais cliniques

Intelligence Artificielle Essais Cliniques Oxurion Jumeaux Numériques Axiodis CRO
BRIEF

published on 09/16/2025 at 18:05, 10 months 21 days ago

Oxurion and Axiodis CRO leverage AI to revolutionize clinical trials

Artificial Intelligence Clinical Trials Oxurion Digital Twins Axiodis CRO
PRESS RELEASE

published on 09/16/2025 at 18:00, 10 months 21 days ago

Axiodis CRO, la filiale française du Groupe Oxurion annonce une double initiative stratégique autour de l'IA pour transformer les essais cliniques
Axiodis CRO lance jumeaux numériques et patients virtuels pour optimiser les essais cliniques intégrant l'IA. Exagis renforcé par l'IA pour des données cliniques fiables et workflows améliorés

IA Jumeaux Numériques Axiodis CRO Patients Virtuels Exagis

Accesswire

Published on 08/08/2026 at 00:00, 19 minutes ago

Boron One Announces Change of Auditor
Published on 08/07/2026 at 23:15, 1 hour 4 minutes ago

Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 1 hour 19 minutes ago

Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 1 hour 49 minutes ago

UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 2 hours 4 minutes ago

Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services

View all ACCESSWIRE

EQS Group

Published on 08/07/2026 at 23:21, 58 minutes ago

EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 19:30, 4 hours 49 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/07/2026 at 19:15, 5 hours 4 minutes ago

ABO Energy Agrees Sale of Its Polish and Hungarian Subsidiaries
Published on 08/07/2026 at 18:10, 6 hours 9 minutes ago

Stabilus SE: Andreas Jaeger steps down as Chief Financial Officer at his own request
Published on 08/07/2026 at 18:00, 6 hours 19 minutes ago

E-PANGO: Composition du capital au 31 juillet 2026

Les Echos

Published on 08/07/2026 at 18:54, 5 hours 25 minutes ago

Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026
Published on 08/07/2026 at 18:54, 5 hours 25 minutes ago

Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 5 hours 39 minutes ago

Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 18:40, 5 hours 39 minutes ago

Déclaration hebdomadaire d'opérations effectuées du 3 au 7 août 2026
Published on 08/07/2026 at 18:00, 6 hours 19 minutes ago

LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 juillet 2026

View all LES ECHOS COMFI WIRE